Objective: A randomised controlled trial (RCT) to assess the effectiveness of nurse-initiated use of albuterol metered-dose inhaler (MDI) to patients for relieving the signs and symptoms of acute exacerbations of chronic obstructive pulmonary disease (COPD) prior to consultation in an emergency department (ED). Design: A single-centre unblinded RCT. Methods: Known COPD Chinese patients who aged at least 18 years old, previous use of albuterol MDI, competent to blow the peak flow meter and complained of dyspnoea. The anticipated time between nurse-initiated use of albuterol MDI and consultation was over five minutes. The subjects were recruited from the ED of a hospital in Hong Kong and were allocated to the albuterol or control group by block randomisation. Six albuterol puffs were administered via a MDI to the albuterol group but not the control group. Peak flow rate, blood oxygen saturation, respiratory rate, adverse effects, ED length of stay and admission rate were assessed before nursed-initiated use of albuterol MDI and prior to consultation. Results: 110 subjects were recruited and randomly allocated into the albuterol (n=55) or control (n=55) group. The PFR increased 2.4 L/minute (p<0.001) in the albuterol group but not in the control group. The oxygen saturation and symptom of dyspnoea also improved in the albuterol group but not in the control group. Conclusions: Nurse-initiated use of albuterol MDI can improve PFR prior to consultation so that it should be recommended as a standard practice in EDs to reduce the suffering of patients with acute exacerbations of COPD. (Hong Kong j.emerg.med. 2012;19:162-170) Although inhaled bronchodilators remain the most im p o r t a n t a n d wi d el y p r es c r i b ed a g e n t s f o r exacerbations of COPD, 3, 5, 8 only few emergency departments (EDs) in Hong Kong authorise triage nurses to initiate their use. After triage, patients with acute exacerbations of COPD have to wait for consultation without treatment except oxygen if they are assigned with a triage category below 2 (including u r g e n t , s e mi -u r g en t a n d n o n -u r g e n t c a s es ) . Accordingly, the majority of them may suffer and some even deteriorate before consultation, especially if the waiting time is long. Albuterol MDI is widely used as a rescue medicine to help relieving the signs and symptoms of exacerbations. However, there is limited evidence on the effectiveness of nurse-initiated use of albuterol MDI in EDs. Previous studies focused mainly on the equivalency of various delivery systems as well as the dose-response effects and optimal treatment interval for albuterol.
Although inhaled bronchodilators remain the most im p o r t a n t a n d wi d el y p r es c r i b ed a g e n t s f o r exacerbations of COPD, 3, 5, 8 only few emergency departments (EDs) in Hong Kong authorise triage nurses to initiate their use. After triage, patients with acute exacerbations of COPD have to wait for consultation without treatment except oxygen if they are assigned with a triage category below 2 (including u r g e n t , s e mi -u r g en t a n d n o n -u r g e n t c a s es ) . Accordingly, the majority of them may suffer and some even deteriorate before consultation, especially if the waiting time is long. Albuterol MDI is widely used as a rescue medicine to help relieving the signs and symptoms of exacerbations. However, there is limited evidence on the effectiveness of nurse-initiated use of albuterol MDI in EDs. Previous studies focused mainly on the equivalency of various delivery systems as well as the dose-response effects and optimal treatment interval for albuterol. 5 Against this backdrop, this study aimed to compare the signs and symptoms of patients wit h a c u t e ex a c er b a t io n s o f C O P D p r io r t o consultation with and without nurse-initiated use of albuterol MDI. It was hypothesised that nurse-initiated use of albuterol MDI will improve peak flow rate (PFR) prior to consultation.
Introduction
Chronic obstructive pulmonary disease (COPD) is predominantly caused by smoking and is characterised by airflow obstruction which is usually progressive and not fully reversible, and does not change markedly over several months. 1 The prevalence of COPD in the elderly above 70 years of age is estimated to be 9% in Hong Kong. 2 COPD limits the functional capacity of a large population and continues to be an increasing cause of morbidity and mortality worldwide. [3] [4] [5] [6] Exacerbations of COPD occur regularly with an annual rate of 2.4 to 3 episodes, represent one of the major contributors to the clinical load of physicians and are associated with impoverished health status and increased mortality. [6] [7] [8] Early recognition and prompt treatment of exacerbations not only improve the clinical progress, but also enhance the health related quality of life and reduce the risk of admission. 8 Inhaled bronchodilators such as short acting  2 -agonists improve airflow obstruction, functional capacity and the quality of life so that they are the main modality for treating exacerbations of COPD. 3, 4, 8 Albuterol is a short acting  2 -agonist which stimulates the production of cyclic adenosine monophosphate to promote the relaxation of airway smooth muscle. 3, 8 It takes effect in 5 minutes with a peak at 30 minutes, declines after 2 to 3 hours and lasts for 4 to 6 hours. 8 The dosage of albuterol metered-dose inhaler (MDI) for exacerbations of COPD is proposed to be 3 to 4 puffs every half to 2 hours. 9 The study of Idris et al showed that 4 albuterol puffs administered via a MDI was equivalent to nebulised treatment. 10 As suggested by the study of Karpel et al, administering 2 additional puffs ensured that the dosage was more than adequate in comparison to nebulised treatment. 5 但在對照組則沒有。結論：護士啟動使用舒喘寧 MDI ，可在醫生看診之前增加高峰流量，所以應該建 議作為標準的做法，以減少在 ED 的慢性阻塞性肺病急性加重患者的痛苦。 Keywords: Bronchodilator, nurse-led, oxygen saturation, peak flow rate
were patients who were pregnant or mentally incompetent, or had allergic history to albuterol or triage category 1 (critical) or 2 (urgent). The subjects were recruited from an ED by means of consecutive convenience sampling. This centre is one of the major general hospitals in Hong Kong. It provides 24-hour service and the daily attendance is approximately 530.
In accordance with the study of Karpel et al, 5 6 albuterol puffs were administered via a MDI which was attached to a spacer to the albuterol group during triage. The subjects were instructed to inhale slowly from the mouthpiece and hold their breath for 5 seconds after inhalation. On the other hand, no albuterol puff was administered to the control group. Placebo MDI was not used because it was no longer available as informed by the supplier.
The primary outcome was the change of PFR in the triage station and prior to consultation. It was measured by a peak flow meter. The best of 3 measurements was used. The secondary outcomes were the change of pulse oximeter oxygen saturation (SpO 2 ), respiratory rate (RR) and heart rate (HR) in the triage station and prior to consultation. Perceptions of dyspnoea, palpitation and tremor change were estimated by a visual analogue scale, SpO 2 was measured by a pulse oximeter, and HR and RR were counted in 1 minute by the assessors. They were assessed by a self-developed data sheet before nurse-initiated use of albuterol MDI during triage and were reassessed prior to consultation. Additional analyses were done on ED length of stay (LOS) which was calculated from the registration time to the discharge time in the accident and emergency information system, and admission rate which included acute and convalescent beds. There was no change in the outcome assessment after the trial commencement.
Since there was probably no previous similar study, the sample size of this study was estimated from the pilot study which was conducted on 10 subjects. The effect size in PFR was 24.2 L/minute. The sample size in each group should be 55 subjects if one-sided significance level and power were set at 5% and 80% respectively.
The investigators generated the random allocation sequence in block of four randomisation. The allocation was concealed in sequentially numbered opaque envelopes. The triage nurses enrolled and assigned the subjects into the albuterol or control group according to this sequence. Intention-to-treat principle was used to maintain the effect of randomisation. The nurses in charge (outcome assessors) were blinded to the assignment of allocation and were responsible for the outcome assessment in the cubicles.
Data were analysed using SPSS 16.0 for Windows (September 13, 2007) . Descriptive statistics including frequency, mean and standard deviation (SD) were used to describe the characteristics of the albuterol and control groups. Inferential statistics including Student's t-test, Mann-Whitney U test, independent samples t-test, Wilcoxon signed-ranks test, Chi square test and Fisher's exact test were used for comparing the characteristics, signs and symptoms, ED LOS and admission rate of both groups. A p-value <0.05 was accepted as statistically significant for all statistical tests. 
Results
The participant flow is presented in Figure 1 . The period of recruitment was between February 2010 and May 2010. One hundred and twelve patients were assessed for eligibility and 12 of them were excluded. One hundred and ten subjects were recruited and randomly allocated into the albuterol (n=55) or control (n=55) group. All the subjects in the albuterol group received triage nurse-initiated albuterol MDI. All subjects in both groups were analysed.
The characteristics of the subjects were presented in Tables 1a and 1b. Their mean age was 76.4 (albuterol) and 74.3 (control) years. Male [albuterol: 41 (74.5%); control: 38 (69.1%)] was dominant in both groups. All the subjects had co-morbid diseases and the mean number was 3.5 (albuterol) and 3.6 (control). About half of the subjects used long-term oxygen therapy [albuterol: 27 (49.1%); control: 24 (43.6%)] and its mean dosage was 1.5 (albuterol) and 1.6 (control) L/ minute. The majority of the subjects complained of dyspnoea for day(s) [albuterol: 31 (56.4%); control: 41 (74.5%)] and were transported to the ED by ambulance [albuterol: 52 (94.5%); control: 49 (89.1%)] in both groups. All the subjects used bronchodilators within six hours whatever they were transported by ambulance or walked in to the ED and were assigned with a triage categor y 3 (urgent). Oxygen was administered to all the subjects during triage and its mean dosage was 2.2 (albuterol) and 2.1 (control) L/ minute. The mean waiting time of the subjects was 22.1 (albuterol) and 28.8 (control) minutes. There was no significant difference in the above baseline parameters.
Only 3 subjects (5.5%) in the albuterol group were ordered with albuterol MDI during consultation and its mean dosage was 6.0 puffs. Conversely, albuterol MDI was ordered in all the subjects in the control group during consultation and its mean dosage was 7.1 puffs. The mean door-to-albuterol time of the albuterol group was 7.6 minutes while that of the control one was 45.6 minutes. All the subjects were ordered with chest X-ray and blood tests, and most of them were disposed before the availability of blood results [albuterol: 46 (83.6%); control: 49 (89.1%)] in both groups. COPD [albuterol: Table 4 showed the comparison of the perceptions of dyspnoea, palpitation and tremor of both groups during triage and prior to consultation. In the albuterol group, there was a significant decrease in the perception of dyspnoea (p<0.001) (population proportion 67.3%, 95% CI 54.1%, 78.2%), and a significant increase in the perception of palpitation (p=0.009) (population proportion 70.9%, 95% CI 57.9%, 81.2%). In the control group, there was a significant increase in the perception of dyspnoea (population proportion 54.5%, 95% CI 41.5%, 67.0%). Table 5 showed the comparison of the ED LOS of both groups using. There was no statistical significance in the ED LOS between both groups (albuterol: 139.9 min; control: 146.6 min) (p=0.398) (mean difference 6.7, 95% CI -9.1, 22.5). Only 3 (5.5%) subjects in the albuterol group and 1 (1.8%) subject in the control group were discharged. There was no statistical significance in the admission rate between both groups (albuterol: 94.5%; control: 98.2%) (p=0.309) (absolute risk reduction 3.7%, 95% CI -13.2%, 4.9%).
Discussion
The PFR was improved after nurse-initiated use of albuterol MDI in this study. Since the PFR was improved, it was not surprising that the SpO 2 was increased and the perception of dyspnoea was lessened by improving airflow obstruction.
Somebody may argue that nurse-initiated use of albuterol MDI is a duplication of treatment if albuterol has already been given in ambulance shortly before patients are transported to the ED. It has been shown that administering 6 albuterol puffs is necessary to ensure more than adequate dosage in comparison to nebulised treatment. 5 However, the standard dosage of albuterol given in ambulance by protocol is 2 puffs which may be sup-optimal for COPD exacerbations. Nurse-initiated use of albuterol MDI could shorten the door-to-albuterol time unquestionably in this study. The albuterol group was administered with albuterol MDI 38 minutes earlier than the control one. Without early treatment, an increase in the perception of dyspnoea in the control group has been shown. On the other hand, the subjects in the albuterol group had less suffering because they were able to receive appropriate treatment earlier. After physician consultation, albuterol MDI was ordered in all the subjects in the control group and its mean dosage was similar to nurse-initiated one. It showed that albuterol MDI was needed in all the subjects and the dosage of nurse-initiated use of albuterol MDI was appropriate.
Increase in HR and perception of palpitation were the only adverse effects of nurse-initiated use of albuterol MDI in this study. These are known adverse effects of albuterol treatment for COPD exacerbations which are minor compared with the treatment benefits.
Nurse-initiated use of albuterol MDI did not shorten the ED LOS in this study. Triage level, consultation, diagnostic imaging and laboratory tests are important independent variables which affect ED LOS.
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In this study, all the subjects in the albuterol and control groups were assigned with a triage category 3, assessed by physicians, ordered with chest X-ray and blood tests, and reassessed by the physicians in sequence. There was no difference in the patient flow between both groups except that albuterol MDI was administered earlier in the albuterol group. As a result, time could not be saved.
The admission rate could not be reduced by nurseinitiated use of albuterol MDI in this study. According to the clinical guideline of National Institute for Clinical Excellence, 16 factors should be used to assess the need for hospital treatment. These are: able to cope at home, breathlessness, general condition, level of activity, cyanosis, worsening peripheral oedema, level of consciousness, already receiving long term oxygen therapy, social circumferences, acute confusion, rapid rate of onset, significant co-morbidity, SpO 2 less than 90%, changes on the chest radiograph, arterial pH level and ar t erial par tial pressure of oxygen. 1 It is understandable that admission rate would unlikely be affected by working on one single factor. For the 3 discharged subjects in the albuterol group, they did not make an un-scheduled return to any ED in Hong Kong within 2 weeks. This might support that nurseinitiated use of albuterol MDI would not alter the assessment of physicians, making them underestimate the severity of exacerbations.
Nurse-initiated use of albuterol MDI is worth applying in EDs according to the 5 killer Bs' of applicability including biology, barrier, belief, burden and bargain. There is a similar spectrum of patients (Biology) and albuterol MDI is readily available (Barrier) in all EDs in Hong Kong. Moreover, it is believed that nurseinitiated use of albuterol MDI can improve PFR, enhance SpO 2 , lessen perception of dyspnoea and shorten door-to-albuterol time with minimal adverse effect prior to consultation (Belief ) in a large volume of case load in EDs (Burden). However, there is no doubt that triage time will be lengthened due to related procedures (Bargain). In this study, it took around 5 minutes to give explanation, obtain written consent, document relevant data and administer albuterol MDI. If nurse-initiated use of albuterol MDI is implemented as a standard practice, it is expected that no more than 2 minutes will be spent because the only procedure is to administer albuterol MDI.
There are several limitations in this study. It may be difficult to generalise the results to other hospital settings and patient populations because this study was only conducted in the ED of a regional hospital in Hong Kong. Hence, future studies should be conducted in multiple centres to ensure generalisability.
There was no blinding in this study so that the results were prone to the risk of Hawthorne effect. In fact, the effect can be minimised by the use of placebo but placebo MDI is no longer available as informed by the supplier. The results of unblinded RCTs tend to be biased towards beneficial effects especially for outcomes that are subjective. 12 In this study, PFR, SpO 2 , RR and HR were objective data which should be less biased. However, perceptions of dyspnoea, palpitation and tremor were subjective and therefore might be biased.
It was impractical to perform spirometry in this study although forced expiratory volume in 1 second (FEV 1 ) is preferable to PFR as a method of diagnosing and checking the progress in COPD. 1 Nevertheless, there is good correlation between FEV 1 and PFR in patients with acute exacerbations of COPD so that PFR can be used as an alternative measure of airflow obstruction in instances in which FEV 1 is unavailable. 13 
Conclusion
In conclusion, nurse-initiated use of albuterol MDI can improve PFR and SpO 2 , lessen perception of dyspnoea while waiting for consultation and shorten door-to-albuterol time with minimal adverse effect prior to consu ltation f or patients with acute exacerbations of COPD. However, it cannot shorten ED LOS and admission rate. It is recommended to make it a standard practice in EDs to reduce the suffering and deterioration of patients, and enhance the autonomy and independence of nurses.
